today announced that CD8 Technology Services LLC (“CD8”) has signed a letter of intent for a facility designed to support Tevogen Bio’s cell therapy manufacturing facility. Tevogen Founder ...

Anaergia Inc. (“Anaergia”, the “Company”, “us”, or “our”) (TSX:ANRG) (OTCQX:ANRGF), through its subsidiary, Anaergia S.r.l., entered into a binding ...

The Company is actively engaged in pioneering the tokenization of real estate assets to create inclusive investment opportunities while delivering high-quality ... signs-letter-of-intent-to ...